The Wolverine Stack is the name the research community gives to BPC-157 and TB-500 supplied together — the two compounds most often studied side by side in the tissue-repair and recovery literature. NextGen's Wolverine Stack is exactly that: one BPC-157 10 mg vial and one TB-500 10 mg vial, sold as a single item for $199 (the two vials separately come to $204.98). This page covers what is in the stack, why the pairing is studied, and how to source it with documentation from Australian stock.
What is the Wolverine Stack?
Unlike a blend such as KLOW, the Wolverine Stack is not a single mixed vial. It is two separately manufactured, separately tested research peptides supplied together: a labelled BPC-157 10 mg vial and a labelled TB-500 10 mg vial, each with its own batch number and Certificate of Analysis. Buying them as the stack simply saves a researcher choosing the pair individually — and a few dollars. It is supplied strictly for laboratory and in-vitro research use.
The "Wolverine" nickname comes from the recovery-research context the two compounds share; it is a community shorthand, not a product claim, and nothing here should be read as a statement about effects in humans.
What is in the stack
- BPC-157 (10 mg) — "Body Protection Compound 157", a synthetic pentadecapeptide derived from a protein found in gastric juice. Studied in gut-lining, tendon-healing and tissue-repair research.
- TB-500 (10 mg) — a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cell repair and movement. Studied in cell-migration, angiogenesis and muscle-recovery research.
These describe fields of scientific study — they are not claims about effects in humans. NextGen Peptides supplies both compounds strictly for laboratory and in-vitro research use.
Why BPC-157 and TB-500 are studied together
The two compounds are examined together so often because their research areas overlap without duplicating each other. BPC-157 is most associated with the local tissue-repair strand of the literature — tendon, ligament and gut-lining models — while TB-500's Thymosin Beta-4 origin puts it in the cell-migration and angiogenesis strand, the mechanics of how cells move into and repair damaged tissue. Researchers working on recovery and repair processes therefore frequently run the pair in parallel, which is why the stack has become a standard pairing rather than a novelty.
Storage & handling
Both vials are supplied as lyophilised (freeze-dried) powder. Store at −20°C. Each vial is reconstituted separately with bacteriostatic water — they are not combined in one vial — then refrigerated at 2–8°C and kept out of light. See our full guide to storing and reconstituting research peptides, what to mix with in our bacteriostatic water guide, and work out concentrations for each vial with the reconstitution calculator. Run diluent slowly down the vial wall and swirl rather than shake; never refreeze a reconstituted solution.
Sourcing the Wolverine Stack in Australia
Both vials are held in Australian stock, so orders placed before the daily cut-off are dispatched same or next business day — no overseas freight, no customs wait. Each batch is independently third-party tested for purity (HPLC) and identity (mass spec), with both Certificates of Analysis published. The stack is $199, against $204.98 for the two vials bought separately; standard bulk pricing applies from three stacks. New to buying research peptides? Read our Australian buyer's guide and the full Peptides Australia guide first.
Common questions about the Wolverine Stack
What is the Wolverine Stack?
BPC-157 and TB-500 supplied together. NextGen's version is two separate vials — BPC-157 10 mg and TB-500 10 mg — sold as one item for laboratory research use only.
Is it one vial or two?
Two. You receive a labelled BPC-157 vial and a labelled TB-500 vial, each with its own batch number and CoA, reconstituted and stored separately.
Why are BPC-157 and TB-500 studied together?
Their research areas overlap in the tissue-repair and recovery field without duplicating: BPC-157 in local tissue-repair models, TB-500 in cell-migration and angiogenesis research.
How much does it cost?
$199 for both vials — $5.98 less than the $204.98 they cost separately. Bulk pricing applies from three stacks.
Is it tested and does it come with a CoA?
Yes. Both vials come from independently tested batches, with each Certificate of Analysis published.
Is it held in Australian stock?
Yes. Both vials are held in Australian stock and dispatched same or next business day for orders placed before the daily cut-off.
Legal status and intended use
The Wolverine Stack is supplied by NextGen Peptides strictly as research chemicals for laboratory and in-vitro use. Neither compound is an approved therapeutic good in Australia, neither is supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over. For the regulatory framework, see our guide to the legal status of research peptides in Australia.
Quick facts
SKU: WOLV-20 · Two vials: BPC-157 10MG + TB-500 10MG · $199 (vs $204.98 separately) · Each batch-tested with published CoA · Held in Australian stock · Same or next business day dispatch · For laboratory research use only.
Related research
Read the full pages for each compound in the stack, both held in Australian stock: BPC-157 and TB-500. Want the pair plus GHK-Cu and KPV in a single vial? See KLOW; for a skin-focused blend, see GLOW.
Part of our complete guide to research peptides in Australia.
Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.